Pregled bibliografske jedinice broj: 541396
FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis
FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis // Cancer research (Baltimore), 71 (2011), 8; 2901-2915 doi:10.1158/0008-5472.CAN-10-1731 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 541396 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis
Autori
Desterke, C. ; Bilhou-Nabera, C. ; Guerton, B. ; Martinaud, C. ; Tonetti, C. ; Clay, D. ; Guglielmelli, P. ; Vannucchi, A. ; Bordessoule, D. ; Hasselbalch, H. ; Dupriez, B. ; Benzoubir, N. ; Bourgeade, M.F. ; Pierre-Louis, O. ; Lazar, V. ; Vainchenker, W. ; Bennaceur-Griscelli, A. ; Gisslinger, H. ; Giraudier, S. ; Le Bousse-Kerdiles, M.C. ; Bourhis, J.H. ; de Botton, S. ; Briere, J. ; Demory, J.L. ; Fenaux, P. ; Kiladjian, J.J. ; Pasquet, J.M. ; Lippert, E. ; Praloran, V. ; Morel, P. ; Rey, J. ; Roy, L. ; Viallard, J.F. ; Barosi, G. ; Cervantes, F. ; Griesshammer, M. ; , Kreipe, H. ; Kvasnicka, H.M. ; Kušec, Rajko ; Marchetti, M. ; Merup, M. ; Pahl, H. ; Palmblad, J. ; Reilly, J.T. ; Skoda, R. ; Thiele, J.
Izvornik
Cancer research (Baltimore) (0008-5472) 71
(2011), 8;
2901-2915
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
FLT3; p38-MAPK; primary myelofibrosis; cancer
Sažetak
Primary myelofibrosis (PMF) is characterized by increased number of hematopoietic progenitors and a dysmegakaryopoiesis which supports the stromal reaction defining this disease. We showed that increased ligand (FL) levels in plasma, hematopoietic progenitors, and stromal cells from PMF patients were associated with upregulation of the cognate Flt3 receptor on megakaryocytic (MK) cells. This connection prompted us to study a functional role for the FL/Flt3 couple in PMF dysmegakaryopoiesis, as a route to reveal insights into pathobiology and therapy in this disease. Analysis of PMF CD34þ and MK cell transcriptomes revealed deregulation of the mitogen-activated protein kinase (MAPK) pathway along with Flt3 expression. In PMF patients, a higherproportion of circulating Flt3þCD34þCD41þ cells exhibited an increased MAPK effector phosphorylation independently of Jak2V617F mutation. Activation of FL/Flt3 axis in PMF MK cell cultures, in response to FL, induced activation of the p38–MAPK cascade, which is known to be involved in inflammation, also increasing expression of its target genes (NFATC4, p53, AP-1, IL-8). Inhibiting Flt3 or MAPK or especially p38 by chemical, antibody, or silencing strategies restored megakaryopoiesis and reduced phosphorylation of Flt3 and p38 pathway effectors, confirming the involvement of Flt3 in PMF dysmegakaryopoiesis via p38 activation. In addition, in contrast to healthy donors, MKcells derived from PMF CD34þ cells exhibited an FL-induced migration that could be reversed by p38 inhibition. Taken together, our results implicate the FL/Flt3 ligand–receptor complex in PMF dysmegakaryopoiesis through persistent p38–MAPK activation, with implications for therapeutic prospects to correct altered megakaryopoiesis in an inflammatory context.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1980955-3094 - Genetika i funkcija hematopoeze i mikrookoliša Ph- mijeloproliferativnih bolesti (Kušec, Rajko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Rajko Kušec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE